Sentinel lymph node (SLN) detection techniques have the potential to change the standard of 23 surgical care of patients with prostate cancer. We performed a lymphatic mapping study and 24 determined the value of fluorescence SLN detection with indocyanine green (ICG) for the 25 detection of lymph node metastases in intermediate-and high-risk patients undergoing radical 26 prostatectomy and extended pelvic lymph node dissection. A total of 42 patients received 27 systematic or specific ICG injections into the prostate base, the mid-portion, the apex, the left 28 lobe or the right lobe. We found that: 1. external and internal iliac regions encompass the 29 majority of SLNs; 2. common iliac regions contain up to 22% of all SLNs; 3. a prostatic lobe can 30 drain into the contralateral group of pelvic lymph nodes; 4. the fossa of Marcille also receives 31 significant drainage. Among the 12 patients who received systematic ICG injections, 5 (42%) had 32 a total of 29 lymph node metastases. Of these, 16 nodes were ICG-positive, yielding 55% 33 sensitivity. The complex drainage pattern of the prostate and the low sensitivity of ICG for the 34 detection of lymph node metastases reported in our study highlight the difficulties related to the 35 implementation of SNL techniques in prostate cancer.
37
Patient summary: There is controversy over how extensive lymph node dissection should be 38 during prostatectomy. We investigated the lymphatic drainage of the prostate and whether 39 sentinel node fluorescence techniques would be useful to detect node metastases. We found that 40 the drainage pattern is complex and that the sentinel node technique is not able to replace 41 extended pelvic lymph node dissection.
Main text 44
The role of pelvic lymph nodes dissection (PLND) during radical prostatectomy (RP) 45 remains a matter of continuous debate (1). Sentinel lymph node (SLN) detection has been 46 advanced as a potential alternative to PLND. In prostate cancer, the technique was first described 47 using 99m technetium bound to a colloid (2). However, radio-guided SLN detection has not come Baseline characteristics of the patients are summarized in Supplementary Table 1 . All 42 70 patients had one or more lymph nodes detected by fluorescence. The lymphatic mapping study 71 showed that ( Fig. 1 and Supplementary Table 2 Table   86 1). Of these, 16 were ICG-positive, yielding a sensitivity for the detection of lymph node 87 metastases of 55%. The negative predictive value was 95%, the specificity was 57%, and the 88 predictive positive value 8%. Repeating analyses with patients as unit of analysis showed that 89 four of five patients had ICG-positive lymph node metastases, yielding a sensitivity for the 90 correct staging of patients of 80%. nodes removed was 35 vs. 18 in both previous reports. These findings suggest that our template 96 leads to a notably more complete PLND, which would result in more precise sensitivity analyses.
97
In addition, our median number of SLNs removed was 15 (IQR 10-20), which is in the higher 98 range of most previous studies using ICG alone or in combination with a radio-colloid (3-6).
99
Other authors may not have searched as thoroughly for SLNs in surgically less accessible regions 100 such as the proximal part of the common iliac vessels, in the fossa of Marcille and in the 101 presacral regions. In Yuen et al's study, only 2% and 1% of all SLNs were found in the common 102 iliac and presacral regions, respectively (5).
103
The low sensitivity of ICG to detect metastases in the current study raises the concern of 104 skip metastases. The presence of tumor cells in the lymph nodes may clog the feeding lymphatics 105 and interfere with their ability to take up ICG, as it has been postulated for radio-colloids (7).
106
Interestingly, we could sometimes visualize that lymphatic drainage goes around enlarged nodes.
107
Going forward, emerging molecular imaging modalities using dyes conjugated with tumor-108 specific peptides may provide added sensitivity (8) (9) (10) . It has to be noted that it is not possible to 109 discriminate with certainty between primary landing sites and higher levels of drainage.
110
However, the fact that fluorescent lymph nodes appeared 15-30 min after ICG injection and that 111 direct drainage through lymphatic vessels could be seen in some cases suggests that these lymph 112 nodes can be considered SLNs. Our study is limited by its small sample size. Nevertheless, it included a high number of lymph node metastases in the setting of extended PLND, allowing 114 appropriate sensitivity analyses.
115
In conclusion, our lymphatic mapping study delineated a complex drainage pattern of the 116 prostate that questions whether targeted lymph node dissection can be implemented in prostate 117 cancer. Together with the low sensitivity for the detection of metastases, these results suggest that 118 for the time being fluorescence SNL detection does not represent an alternative to a meticulously 119 performed PLND in higher-risk patients. 
